Skip to content 
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska. more
| Time Frame | KLTO | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -1.26% | -0.33% | -1.49% |
| 1-Month Return | 32.6% | -4.57% | -0.37% |
| 3-Month Return | -44.02% | -9.96% | 3.89% |
| 6-Month Return | -73.17% | -5.67% | 9.34% |
| 1-Year Return | -95.66% | 2.53% | 25.19% |
| 3-Year Return | -95.31% | -1.43% | 24.7% |
| Dec '21 | Dec '22 | |||||
|---|---|---|---|---|---|---|
| Total Revenue | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}] | |||
| Cost of Revenue | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}] | |||
| Gross Profit | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}] | |||
| Gross Margin | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}] | |||
| Operating Expenses | 1.11M | 574.37K | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":51.79,"profit":true}] | |||
| Operating Income | (1.11M) | (574.37K) | [{"date":"2021-12-31","value":-110906900,"profit":false},{"date":"2022-12-31","value":-57437400,"profit":false}] | |||
| Total Non-Operating Income/Expense | 44.00 | (24.22K) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-55043.18,"profit":false}] | |||
| Pre-Tax Income | (1.11M) | (598.59K) | [{"date":"2021-12-31","value":-110902500,"profit":false},{"date":"2022-12-31","value":-59859300,"profit":false}] | |||
| Income Taxes | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}] | |||
| Income After Taxes | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}] | |||
| Income From Continuous Operations | (1.11M) | (598.59K) | [{"date":"2021-12-31","value":-110902500,"profit":false},{"date":"2022-12-31","value":-59859300,"profit":false}] | |||
| Income From Discontinued Operations | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}] | |||
| Net Income | (1.11M) | (598.59K) | [{"date":"2021-12-31","value":-110902500,"profit":false},{"date":"2022-12-31","value":-59859300,"profit":false}] | |||
| EPS (Diluted) | - | 0.08 | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true}] | |||
These ratios help you determine the liquidity of the company. Higher is better.
| KLTO | |
|---|---|
| Current Ratio | 1.11 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| KLTO | |
|---|---|
| ROA (LTM) | -23.57% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| KLTO | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 1.47 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.47 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| KLTO | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 43.36 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Klotho Neurosciences, Inc. (KLTO) share price today is $0.47
Yes, Indians can buy shares of Klotho Neurosciences, Inc. (KLTO) on Vested. To buy Klotho Neurosciences, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KLTO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Klotho Neurosciences, Inc. (KLTO) via the Vested app. You can start investing in Klotho Neurosciences, Inc. (KLTO) with a minimum investment of $1.
You can invest in shares of Klotho Neurosciences, Inc. (KLTO) via Vested in three simple steps:
The 52-week high price of Klotho Neurosciences, Inc. (KLTO) is $13.1. The 52-week low price of Klotho Neurosciences, Inc. (KLTO) is $0.26.
The price-to-earnings (P/E) ratio of Klotho Neurosciences, Inc. (KLTO) is
The price-to-book (P/B) ratio of Klotho Neurosciences, Inc. (KLTO) is 43.36
The dividend yield of Klotho Neurosciences, Inc. (KLTO) is 0.00%
The market capitalization of Klotho Neurosciences, Inc. (KLTO) is $17.65M
The stock symbol (or ticker) of Klotho Neurosciences, Inc. is KLTO
Link copied 
